Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 1.07
(-0.09%)
EUR 1.07
(-0.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 42.15 Million EUR | 19.51% |
| 2022 | 35.27 Million EUR | -4.57% |
| 2021 | 36.96 Million EUR | 14.81% |
| 2020 | 32.19 Million EUR | 3.81% |
| 2019 | 31.01 Million EUR | 27.49% |
| 2018 | 24.32 Million EUR | -10.3% |
| 2017 | 27.11 Million EUR | -27.52% |
| 2016 | 37.41 Million EUR | 2.95% |
| 2015 | 36.33 Million EUR | 47.58% |
| 2014 | 24.62 Million EUR | 10.6% |
| 2013 | 22.26 Million EUR | -20.38% |
| 2012 | 27.96 Million EUR | 31.51% |
| 2011 | 21.26 Million EUR | 16.55% |
| 2010 | 18.24 Million EUR | 16.46% |
| 2009 | 15.66 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 22.87 Million EUR | 0.0% |
| 2023 Q4 | 21.33 Million EUR | 0.0% |
| 2023 Q2 | 20.81 Million EUR | 190925.05% |
| 2023 FY | 42.15 Million EUR | 19.51% |
| 2023 Q1 | 10.89 Thousand EUR | -99.93% |
| 2022 Q4 | 16.71 Million EUR | 0.0% |
| 2022 FY | 35.27 Million EUR | -4.57% |
| 2022 Q2 | 18.55 Million EUR | 95.43% |
| 2022 Q1 | 9.49 Million EUR | -49.03% |
| 2021 FY | 36.96 Million EUR | 14.81% |
| 2021 Q1 | 9.75 Million EUR | -41.18% |
| 2021 Q2 | 18.33 Million EUR | 87.84% |
| 2021 Q4 | 18.63 Million EUR | 0.0% |
| 2020 Q1 | 8.67 Million EUR | -48.76% |
| 2020 Q3 | 8.94 Million EUR | -42.67% |
| 2020 Q2 | 15.6 Million EUR | 79.88% |
| 2020 Q4 | 16.59 Million EUR | 85.48% |
| 2020 FY | 32.19 Million EUR | 3.81% |
| 2019 FY | 31.01 Million EUR | 27.49% |
| 2019 Q4 | 16.92 Million EUR | 81.15% |
| 2019 Q3 | 9.34 Million EUR | 20.77% |
| 2019 Q1 | 7.73 Million EUR | 2.81% |
| 2019 Q2 | 7.73 Million EUR | 0.0% |
| 2018 Q1 | 6.27 Million EUR | -22.26% |
| 2018 FY | 24.32 Million EUR | -10.3% |
| 2018 Q4 | 7.52 Million EUR | 0.0% |
| 2018 Q3 | 7.52 Million EUR | 19.88% |
| 2018 Q2 | 6.27 Million EUR | 0.0% |
| 2017 FY | 27.11 Million EUR | -27.52% |
| 2017 Q3 | 8.07 Million EUR | 13.23% |
| 2017 Q4 | 8.07 Million EUR | 0.0% |
| 2017 Q1 | 7.13 Million EUR | -36.28% |
| 2017 Q2 | 7.13 Million EUR | 0.0% |
| 2016 FY | 37.41 Million EUR | 2.95% |
| 2016 Q3 | 11.19 Million EUR | 18.46% |
| 2016 Q4 | 11.19 Million EUR | 0.0% |
| 2016 Q1 | 9.44 Million EUR | -18.27% |
| 2016 Q2 | 9.44 Million EUR | 0.0% |
| 2015 Q2 | 7.7 Million EUR | 0.0% |
| 2015 Q4 | 11.55 Million EUR | 0.0% |
| 2015 Q3 | 11.55 Million EUR | 49.96% |
| 2015 Q1 | 7.7 Million EUR | -6.38% |
| 2015 FY | 36.33 Million EUR | 47.58% |
| 2014 Q4 | 8.23 Million EUR | 0.0% |
| 2014 FY | 24.62 Million EUR | 10.6% |
| 2014 Q3 | 8.23 Million EUR | 74.05% |
| 2014 Q1 | 4.73 Million EUR | -32.86% |
| 2014 Q2 | 4.73 Million EUR | 0.0% |
| 2013 Q2 | 4.58 Million EUR | 0.0% |
| 2013 Q1 | 4.58 Million EUR | 0.0% |
| 2013 FY | 22.26 Million EUR | -20.38% |
| 2013 Q4 | 7.04 Million EUR | 0.0% |
| 2013 Q3 | 7.04 Million EUR | 53.71% |
| 2012 FY | 27.96 Million EUR | 31.51% |
| 2011 FY | 21.26 Million EUR | 16.55% |
| 2010 FY | 18.24 Million EUR | 16.46% |
| 2009 FY | 15.66 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Affluent Medical SA | 1.22 Million EUR | -3343.873% |
| Bluelinea Société Anonyme | 9826.00 EUR | -428894.504% |
| Carmat SA | 2.84 Million EUR | -1380.091% |
| Euromedis Groupe | 37.42 Million EUR | -12.622% |
| Eurobio Scientific Société anonyme | 130.64 Million EUR | 67.735% |
| Ikonisys S.A. | 448.55 Thousand EUR | -9297.468% |
| Implanet S.A. | 7.44 Million EUR | -466.04% |
| Median Technologies SA | 22.22 Million EUR | -89.656% |
| SpineGuard SA | 4.31 Million EUR | -877.393% |
| Theraclion SA | 1.82 Million EUR | -2213.276% |
| Euroapi S.A. | 1.01 Billion EUR | 95.863% |
| Guerbet SA | 785.69 Million EUR | 94.635% |